P‐score in preoperative biopsies accurately predicts P‐score in final pathology at radical prostatectomy in patients with localized prostate cancer

Author:

Röbeck Pontus1ORCID,Xu Lidi2,Ahmed Dilruba2,Dragomir Anca34,Dahlman Pär5,Häggman Michael1,Ladjevardi Sam1

Affiliation:

1. Department of Urology Uppsala University Hospital Uppsala Sweden

2. Prostatype Genomics AB Stockholm Sweden

3. Department of Pathology Uppsala University Hospital Uppsala Sweden

4. Department of Immunology, Genetics and Pathology Uppsala University Uppsala Sweden

5. Department of Surgical Sciences, Radiology Uppsala University Hospital Uppsala Sweden

Abstract

AbstractBackgroundProstate cancer (PCa) is a highly heterogeneous, multifocal disease, and identification of clinically significant lesions is challenging, which complicates the choice of adequate treatment. The Prostatype® score (P‐score) is intended to guide treatment decisions for newly diagnosed PCa patients based on a three‐gene signature (IGFBP3, F3, and VGLL3) and clinicopathological information obtained at diagnosis. This study evaluated association of the P‐score measured in preoperative magnetic resonance imaging/transrectal ultrasound fusion‐guided core needle biopsies (CNBs) and the P‐score measured in radical prostatectomy (RP) specimens of PCa patients. We also evaluated the P‐score association with the pathology of RP specimens. Furthermore, concordance of the P‐score in paired CNB and RP specimens, as well as in index versus concomitant nonindex tumor foci from the same RP was investigated.MethodsThe study included 100 patients with localized PCa. All patients were diagnosed by CNB and underwent RP between 2015 and 2018. Gene expression was assessed with the Prostatype® real‐time quantitative polymerase chain reaction kit and the P‐score was calculated. Patients were categorized into three P‐score risk groups according to previously defined cutoffs.ResultsFor 71 patients, sufficient CNB tumor material was available for comparison with the RP specimens. The CNB‐based P‐score was associated with the pathological T‐stage in RP specimens (p = 0.02). Moreover, the CNB‐based P‐score groups were in substantial agreement with the RP‐based P‐score groups (weighted κ score: 0.76 [95% confidence interval, 95% CI: 0.60–0.92]; Spearman's rank correlation coefficient r = 0.83 [95% CI: 0.74–0.89]; p < 0.0001). Similarly, the P‐score groups based on paired index tumor and concomitant nonindex tumor foci (n = 64) were also in substantial agreement (weighted κ score: 0.74 [95% CI: 0.57–0.91]; r = 0.83 [95% CI: 0.73–0.89], p < 0.0001).ConclusionsOur findings suggest that the P‐score based on preoperative CNB accurately reflects the pathology of the whole tumor, highlighting its value as a decision support tool for newly diagnosed PCa patients.

Publisher

Wiley

Subject

Urology,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3